Zhejiang New Jing Pharmaceutical

Zhejiang New Jing Pharmaceutical is a specialized pharmaceutical company based in Linhai, China, primarily focused on the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Established in 1998, the company has built a strong reputation in the global market for its high-quality production of anti-diabetic agents, cardiovascular drugs, and antifungal treatments. Its facilities are GMP-certified, supporting a robust export business to regions including Europe, Southeast Asia, and South America. The company emphasizes technological innovation and quality control to maintain its position as a key supplier in the pharmaceutical supply chain. It is particularly recognized for its production of sulfonylurea-class medications used in the management of type 2 diabetes.